SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is seeing intense investor activity driven by a new defense contract win and significant high-volume trading that many in the community interpret as institutional accumulation. Market participants are actively debating whether these factors signal a fundamental bottom or if the stock remains vulnerable to further volatility as they await upcoming earnings.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is generating significant buzz following the announcement of a major device leasing partnership with Apple, which has sparked intense community discussion about the company's growth potential and its broader push into becoming a comprehensive financial super app. Investors are closely monitoring the stock's momentum as they weigh the positive implications of this deal against ongoing legal developments and anticipation surrounding the upcoming earnings report.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp is trending as investors monitor a breakout attempt toward key resistance levels, with the community actively debating whether the stock represents a long-term value play or a potential short squeeze candidate. Sentiment remains polarized between bulls citing growth metrics and upward price action as signs of institutional accumulation, and skeptics who remain wary of historical volatility and price suppression.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is experiencing significant community interest and volatility following a White House executive order aimed at fast-tracking FDA reviews for psychedelic-based mental health treatments. Investors are closely monitoring the stock as it navigates a leadership transition and high-stakes Phase 3 trial enrollment, fueling speculation about its potential as an acquisition target or long-term growth play.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Digital is experiencing high volatility as investors weigh the implications of potential excess compute supply in the AI sector against strong, long-term infrastructure demand. The community is actively debating whether this pullback represents a fundamental shift or a temporary consolidation, with many investors focusing on the company's secured power assets and institutional liquidity as indicators of future strength.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple (XRP) is seeing intense community discussion surrounding the anticipated Clarity Act, as traders weigh potential regulatory breakthroughs against persistent price stagnation. While some investors are optimistic about institutional adoption and geopolitical shifts in crypto regulation, others remain skeptical, pointing to the asset's historical struggle to decouple from Bitcoin and overcome ongoing sell pressure.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines Inc. is trending as investors rotate capital into domestic drone manufacturing and defense technology, driven by ongoing discussions around potential U.S. government funding and national security supply chain requirements. The community remains highly focused on the company's strategic manufacturing expansion in Florida and its pivotal role as a supplier for broader drone-defense ecosystems, with active debate regarding potential catalysts from defense policy updates and the stock's recent volatility.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

General Motors is trending as investors digest a strong earnings beat and raised full-year guidance, with community sentiment fueled by the automaker's improved profit margins and disciplined capital allocation. Discussions remain heavily focused on how these operational tailwinds square against long-term uncertainty regarding its evolving EV strategy and broader exposure to global tariff policies.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is seeing heightened market interest and volatility driven by its transition into full production for a major defense contract and the commissioning of critical domestic infrastructure, including a new flotation mill in Montana. The community remains focused on the company's role as a sole-source domestic supplier of antimony for U.S. national security, with ongoing debates centering on the impact of government defense spending, geopolitical tensions, and perceived short-selling pressure.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is capturing market attention as the quantum sector receives heightened government focus, including recent executive orders aimed at accelerating national leadership and research. While retail investors remain active in discussing price volatility and potential technical breakouts, community sentiment is sharply divided between those tracking the stock's support levels for long-term growth and others cautioning about insider selling and the company's path to commercial profitability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RHHBY's Gazyva Gets FDA Priority Review for Label Expansion 

Roche wins FDA Priority Review for Gazyva in primary membranous nephropathy, with a decision due by November 2026 after positive phase III data.

Company News for July 13, 2026

Companies In The Article Are:WDFC,DAL,NRIX and FCX

Nurix Therapeutics, Inc. (NRIX) Reports Q2 Loss, Lags Revenue Estimates

Nurix Therapeutics (NRIX) delivered earnings and revenue surprises of -10.96% and -36.76%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?

A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs

A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs PR Newswire SAN FRANCISCO, July 6, 2026 Issued on...

Roche Reports Positive Results From Head-to-Head Study on NSCLC Drug 

RHHBY announces positive phase III Krascendo 1 results for divarasib in KRAS G12C NSCLC, showing PFS and OS gains versus approved inhibitors.

Earnings Preview: Nurix Therapeutics, Inc. (NRIX) Q2 Earnings Expected to Decline

Nurix Therapeutics (NRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Wall Street Analysts Believe Nurix Therapeutics (NRIX) Could Rally 29.23%: Here's is How to Trade

The mean of analysts' price targets for Nurix Therapeutics (NRIX) points to a 29.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Roche Gets FDA Priority Review for Enspryng in Thyroid Eye Disease

Roche won FDA priority review for Enspryng in thyroid eye disease, with a decision date in October and phase III data backing the filing.

Nurix Therapeutics, Inc. (NRIX) Price Target Raised to $33 on Roche Partnership Value

Nurix Therapeutics, Inc. (NRIX) Price Target Raised to $33 on Roche Partnership Value...

Nurix Stock Up 29% in a Month: Here's What You Should Know

NRIX rallies on its collaboration with Roche for bexobrutideg, featuring a $700 million upfront payment and potential milestone payouts of up to $2.3 billion.

Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in Brisbane, CA.

Nurix Therapeutics Inc

NRIX Stock Surges Nearly 70% Premarket Today – Roche And Nurix’s Blood Cancer Drug Collaboration Can Tap A $41B Market

Equity

Neutral Sentiment

Too early to tell

Memory stocks have been under significant selling pressure in recent weeks. Is the selloff done? Cast your vote and drop your reasoning in the comments.

Is the pullback in memory stocks over? 
 
Explain your reasoning in the comments.

Feed

News

Sentiment

Earnings

Fundamentals

Info

NRIXNurix Therapeutics Inc

Latest NRIX News